entity

Ua

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Ua: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

7Connections

30Hypotheses

0Analyses

7Outgoing

0Incoming

20Experiments

0Debates

No AI portrait yet

Outgoing (7)

Target	Relation	Type	Str
Neuroinflammation	inhibits	process	0.95
NF-κB	inhibits	pathway	0.90
TNF-Α	downregulates	protein	0.90
IL-6	downregulates	protein	0.90
IL-1Β	downregulates	protein	0.90
Intracerebral Hemorrhage	treats	disease	0.85
Microglial M1 Polarization	inhibits	process	0.85

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-S	0.811	neurodegeneration	What are the cell-type-specific transcri
Dual-Receptor Antibody Shuttling	0.803	Alzheimer's disease	-
SASP-Driven Aquaporin-4 Dysregulation	0.782	neurodegeneration	Senolytic therapy for age-related neurod
Dual-Circuit Tau Vulnerability Cascade	0.774	neuroscience	Circuit-level neural dynamics in neurode
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu	0.773	neurodegeneration	Blood-brain barrier transport mechanisms

Aquaporin-4 Polarization Rescue	0.732	neurodegeneration	4R-tau strain-specific spreading pattern
NLRP3 Inflammasome Lock Perpetuates Senescence-Associated In	0.720	neurodegeneration	What molecular mechanisms drive microgli
H2: Indole-3-Propionate (IPA) as the Actual Neuroprotective	0.699	neurodegeneration	How does engineered C. butyricum cross t
Dissociating SCFA's Dual Signaling Through GPR43/GPR41 Biase	0.670	neurodegeneration	Do SCFAs directly modulate α-synuclein a
Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu	0.668	neurodegeneration	Perivascular spaces and glymphatic clear
NeuroD1-Mediated Astrocyte Reprogramming Attenuates Neuroinf	0.650	neurodegeneration	epigenetic reprogramming aging neurons
Dual Calpain/Cathepsin B Inhibition as Primary Neuroprotecti	0.644	neurodegeneration	Why does autophagy inhibition improve ne
Quantum Coherence Disruption in Cellular Communication	0.627	neurodegeneration	Microglia-astrocyte crosstalk amplificat
Cardiovascular-Neuroinflammatory Dual Targeting	0.627	neurodegeneration	Neuroinflammation and microglial priming
Galectin-3 deletion attenuates NLRP3 inflammasome activation	0.625	neuroscience	Lysosomal dysfunction and cathepsin leak
Subtle NMDAR Inhibition Attenuates Excitotoxicity-Driven Tau	0.620	neurodegeneration	Investigate prion-like spreading of tau
DAPK1 Inhibition as Dual-Mechanism Neuroprotection Against T	0.604	neurodegeneration	Should microtubule-stabilizing drugs be
Temporal Decoupling of CSF p-tau217 Normalization from Amylo	0.595	neurodegeneration	-
Residual Vascular Amyloid Prevents Complete CSF p-tau217 Nor	0.585	-	Can CSF p-tau217 normalization serve as
H7: Dual-Target Strategy (Senolytics + APOE4→3 Conversion)	0.580	neurodegeneration	Do APOE4-driven senescent astrocytes cau
Female Microglia Exhibit Reduced P2Y12 Expression Conferring	0.580	neuroinflammation	How do regional, age, and sex-dependent
Dual-Circuit Tau Vulnerability Cascade with Glial-Mediated A	0.568	neuroscience	Circuit-level neural dynamics in neurode
Conserved G-Quadruplex Forming Potential in HOTAIR Defines T	0.568	molecular biology	What are the conserved secondary structu
GCH1/BH4 Axis Stabilization for Dual Ferroptosis and Mitocho	0.560	-	Ferroptosis in ALS and motor neuron dise
Dual NF-κB/MMP Inhibition Strategy	0.554	-	Blood-brain barrier tight junction disru
Dual-Mechanism Model: G2019S Increases Both Baseline AND Sig	0.550	neurodegeneration	Do pathogenic LRRK2 mutations amplify vo
Transient OCT4/SOX2/KLF4/c-MYC Expression Reverses Epigeneti	0.540	neurodegeneration	epigenetic reprogramming aging neurons
APOE4 dual function: beneficial astrocyte anti-inflammatory	0.000	Alzheimer's disease	How does APOE4's beneficial immune funct
CREB1-Induced lncRNA-9969 Selectively Sequesters miR-6361 Th	0.000	molecular neurobiology	How does lncRNA-0021 achieve sequence-sp
CREB1-Induced lncRNA-9969 Selectively Binds miR-6361 Through	0.000	molecular neurobiology	How does lncRNA-0021 achieve sequence-sp

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (20)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Plasma ATN biomarkers across AD continuum in Chilean cohort	clinical	Alzheimer's disease	0.950	0.00	Chilean older adults (n=318) w	proposed	N/A
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Co	clinical	Alzheimer's Disease	0.900	0.50	aortic endothelial cells	proposed	$6,550,000
Tau depletion effects on neuronal development in primary cultures	exploratory		0.900	0.00	primary rodent neuronal cultur	proposed	N/A
Differential GWAS of schizophrenia vs PTSD	exploratory	schizophrenia, post-traumatic	0.900	0.00	human patients - European ance	proposed	N/A
Tau depletion effects on neuronal development in primary cultures	exploratory		0.900	0.00	primary rodent neuronal cultur	proposed	N/A
Creation and validation of 3xAD-ChAT-Cre mouse model	validation	Alzheimer's disease	0.900	0.00	3xAD-ChAT-Cre transgenic mice	proposed	N/A
Development and validation of triple knock-in humanized mice	validation	COVID-19/SARS-CoV-2 infection	0.900	0.00	Triple knock-in mice expressin	proposed	N/A
TREK-1 regulation of conventional outflow facility in mouse eyes	validation	ocular hypertension	0.900	0.00	mouse eyes	proposed	N/A
DEX effects on TREK-1 currents in human primary TM cells	exploratory	corticosteroid-induced ocular	0.900	0.00	primary human trabecular meshw	proposed	N/A
TREK-1 effects on IOP in DEX-induced mouse OHT model	validation	dexamethasone-induced ocular h	0.900	0.00	mouse eyes	proposed	N/A
DEX effects on K2P channel transcriptome in mouse TM cells	exploratory	corticosteroid-induced ocular	0.900	0.00	mouse trabecular meshwork cell	proposed	N/A
GTEx brain tissue expression analysis of MAPT/CRHR1 locus	exploratory	schizophrenia, post-traumatic	0.850	0.00	human brain tissue samples fro	proposed	N/A
Microtubule domain analysis in adult axons	exploratory		0.800	0.00	adult rodent axons	proposed	N/A
Tau depletion effects on microtubule domains in adult axons	exploratory		0.800	0.00	adult rodent neurons	proposed	N/A
Pharmacokinetic evaluation of humanized mAbs in IgG1-Fc humanized mice	validation		0.800	0.00	IgG1-Fc humanized hFCGRT trans	proposed	N/A
TREK-1 effects on spontaneous OHT in rats using telemetry	validation	spontaneous ocular hypertensio	0.800	0.00	rat eyes	proposed	N/A
TREK-1 localization in trabecular meshwork by immunohistochemistry	exploratory	ocular hypertension	0.800	0.00	trabecular meshwork tissue	proposed	N/A
Proposed experiment from debate on Perivascular spaces and glymphatic	falsification	Neurodegeneration	0.400	0.50	mouse	proposed	$240,000
s:** - Test tau spreading in AQP4 knockout vs wild-type mice with PSP/	falsification	Neurodegeneration	0.400	0.50	mouse	proposed	$260,000
Proposed experiment from debate on Perivascular spaces and glymphatic	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$100,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Aquaporin-4 in glymphatic system, and its implication for central nervous system [PMID:36796590]	Peng S, Liu J, Liang C, Yang L, Wang G	Neurobiol Dis	2023	2
Uncommon inflammatory/immune-related myelopathies. [PMID:34715593]	Valencia-Sanchez C, Flanagan EP	J Neuroimmunol	2021	2
Novel function of TREK-1 in regulating adipocyte differentiation and lipid accum [PMID:40057491]	Kim A, Jung S, Kim Y, Jung J, Lee S, Lee	Cell Death Dis	2025	1
Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease. [PMID:40425446]	Sehlin D, Hultqvist G, Michno W, Aguilar	J Prev Alzheimers Dis	2025	1
Mechano- and Glucocorticoid-Sensitive TREK-1 Channels Regulate Conventional Outf [PMID:41268978]	Redmon SN, Yarishkin O, Rudzitis CN, Lak	Invest Ophthalmol Vis Sci	2025	1
A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy [PMID:40020261]	Ana-Sosa-Batiz F, Verma SK, Shafee N, Mi	EBioMedicine	2025	1
B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4. [PMID:38383779]	Afzali AM, Nirschl L, Sie C, Pfaller M,	Nature	2024	1
Activation of TREK-1 (K(2P)2.1) potassium channels protects against influenza A- [PMID:36410022]	Zyrianova T, Lopez B, Zou K, Gu C, Pham	Am J Physiol Lung Cell Mol Phy	2023	1
The importance of FcRn in neuro-immunotherapies: From IgG catabolism, FCGRT gene [PMID:33717213]	Dalakas MC, Spaeth PJ	Ther Adv Neurol Disord	2021	1
Functional humanization of immunoglobulin heavy constant gamma 1 Fc domain human [PMID:33025844]	Low BE, Christianson GJ, Lowell E, Qin W	MAbs	2020	1
Glymphatic System Impairment in Alzheimer's Disease and Idiopathic Normal Pressu [PMID:31959516]	Reeves BC, Karimy JK, Kundishora AJ, Mes	Trends Mol Med	2020	1
Inebilizumab-cdon. [PMID:32936251]	Unknown	American journal of health-sys	2020	1
Multiethnic meta-analysis identifies ancestry-specific and cross-ancestry loci f [PMID:30061609]	Wyss AB, Sofer T, Lee MK, Terzikhan N, N	Nat Commun	2018	1
The glymphatic pathway in neurological disorders. [PMID:30353860]	Rasmussen MK, Mestre H, Nedergaard M	Lancet Neurol	2018	1
Temperature sensitivity of two-pore (K2P) potassium channels. [PMID:25366235]	Schneider ER, Anderson EO, Gracheva EO,	Curr Top Membr	2014	1
TREK-king the blood-brain-barrier. [PMID:24557892]	Bittner S, Ruck T, Fernández-Orth J, Meu	J Neuroimmune Pharmacol	2014	1
Sleep drives metabolite clearance from the adult brain. [PMID:24136970]	Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Th	Science	2013	1
Impact of Neonatal Fc Receptor on Transferrin Receptor Antibody Fusion Protein P [PMID:41755010]	["Oyegbesan A", "Jagadeesan N", "Chandra	Pharmaceutics	2026	0
ROS-responsive nanogels for brain targeted delivery of icariin in the treatment [PMID:41197818]	["Li X", "Huang J", "Zhou Y", "Chen X",	International journal of pharm	2026	0
Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of [PMID:41422555]	Mishra AK, Jain S	ACS Chem Neurosci	2026	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning Ua in their description or question text

Aquaporin-4 Polarization Rescue

Score: 0.732 · neurodegeneration · 2026-04-02

## Mechanistic Overview Aquaporin-4 Polarization Rescue starts from the claim that modulating AQP4 within the disease co

NLRP3 Inflammasome Lock Perpetuates Senescence-Associated Inflammasome Phenotype

Score: 0.720 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The NLRP3 (NACHT, LRR and PYD domains-containing protein 3) inflammasome represen

H2: Indole-3-Propionate (IPA) as the Actual Neuroprotective Effector

Score: 0.699 · neurodegeneration · 2026-04-15

## Mechanistic Overview H2: Indole-3-Propionate (IPA) as the Actual Neuroprotective Effector starts from the claim that

Dissociating SCFA's Dual Signaling Through GPR43/GPR41 Biased Agonism

Score: 0.670 · neurodegeneration · 2026-04-13

## Mechanistic Overview Dissociating SCFA's Dual Signaling Through GPR43/GPR41 Biased Agonism starts from the claim that

Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation

Score: 0.668 · neurodegeneration · 2026-04-02

## Mechanistic Overview Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation starts from the claim that mo

NeuroD1-Mediated Astrocyte Reprogramming Attenuates Neuroinflammation Through Ep

Score: 0.650 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The molecular foundation of this therapeutic approach centers on the dual functio

Dual Calpain/Cathepsin B Inhibition as Primary Neuroprotective Strategy

Score: 0.644 · neurodegeneration · 2026-04-15

## Mechanistic Overview Dual Calpain/Cathepsin B Inhibition as Primary Neuroprotective Strategy starts from the claim th

Quantum Coherence Disruption in Cellular Communication

Score: 0.627 · neurodegeneration · 2026-04-02

## Mechanistic Overview Quantum Coherence Disruption in Cellular Communication starts from the claim that modulating TUB

Cardiovascular-Neuroinflammatory Dual Targeting

Score: 0.627 · neurodegeneration · 2026-04-04

## Mechanistic Overview Cardiovascular-Neuroinflammatory Dual Targeting starts from the claim that modulating TNF/IL6 wi

Galectin-3 deletion attenuates NLRP3 inflammasome activation downstream of lysos

Score: 0.625 · neuroscience · 2026-04-22

**Molecular Mechanism and Rationale** Galectin-3 (LGALS3) functions as a critical molecular sensor and platform orchest

Subtle NMDAR Inhibition Attenuates Excitotoxicity-Driven Tau Release from Hypers

Score: 0.620 · neurodegeneration · 2026-04-22

## Mechanistic Overview Subtle NMDAR Inhibition Attenuates Excitotoxicity-Driven Tau Release from Hypersynchronized Circ

DAPK1 Inhibition as Dual-Mechanism Neuroprotection Against Tau-Induced Destabili

Score: 0.604 · neurodegeneration · 2026-04-15

## Mechanistic Overview DAPK1 Inhibition as Dual-Mechanism Neuroprotection Against Tau-Induced Destabilization starts fr

Residual Vascular Amyloid Prevents Complete CSF p-tau217 Normalization, Requirin

Score: 0.585 · unknown disease · 2026-04-26

Cerebral amyloid angiopathy (CAA) maintains a reservoir of vascular amyloid that continues to drive tau pathology even a

H7: Dual-Target Strategy (Senolytics + APOE4→3 Conversion)

Score: 0.580 · neurodegeneration · 2026-04-22

## Mechanistic Overview H7: Dual-Target Strategy (Senolytics + APOE4→3 Conversion) starts from the claim that modulating